Supplementary Figure 4 from Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer

Authors :: Josep Tabernero
Dominic Smethurst
Elwyn Loh
Jennifer Gansert
Lisa Chen
Kelly S. Oliner
Ian McCaffery
Rui Tang
Hongjie Deng
Hans Prenen
Elena Elez
Joe Stephenson
Irina Davidenko
Edith Mitchell
Niall C. Tebbutt
Anna Świeboda-Sadlej
Elzbieta Nowara
Cathy Eng
Eric Van Cutsem
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 37K, Supplemental Fig. S4. The effect of baseline IGF and IGF-related protein expression on overall survival.

Tools